|Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial|
JW Murrough, L Soleimani, KE DeWilde, KA Collins, KA Lapidus, ...
Psychological medicine 45 (16), 3571, 2015
|Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine|
MS Lener, MJ Niciu, ED Ballard, M Park, LT Park, AC Nugent, ...
Biological psychiatry 81 (10), 886-897, 2017
|In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature|
MS Lener, DV Iosifescu
Annals of the New York Academy of Sciences 1344 (1), 50-65, 2015
|White matter abnormalities in schizophrenia and schizotypal personality disorder|
MS Lener, E Wong, CY Tang, W Byne, KE Goldstein, NJ Blair, ...
Schizophrenia bulletin 41 (1), 300-310, 2015
|Handedness, heritability, neurocognition and brain asymmetry in schizophrenia|
A Deep-Soboslay, TM Hyde, JP Callicott, MS Lener, BA Verchinski, ...
Brain 133 (10), 3113-3122, 2010
|Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.|
ZC Lener MS, Kadriu B
|Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls|
TM Hyde, TE Goldberg, MF Egan, MC Lener, DR Weinberger
The British Journal of Psychiatry 191 (2), 120-125, 2007
|Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales|
ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ...
Journal of affective disorders 231, 51-57, 2018
|Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder|
B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ...
Molecular psychiatry 23 (7), 1626-1631, 2018
|Cortical abnormalities and association with symptom dimensions across the depressive spectrum|
MS Lener, P Kundu, E Wong, KE Dewilde, CY Tang, P Balchandani, ...
Journal of affective disorders 190, 529-536, 2016
|Neurophysiological changes associated with antidepressant response to ketamine not observed in a negative trial of scopolamine in major depressive disorder|
L Park, M Furey, AC Nugent, C Farmer, J Ellis, J Szczepanik, MS Lener, ...
International Journal of Neuropsychopharmacology 22 (1), 10-18, 2019
|A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression|
LT Park, MS Lener, DA Luckenbaugh, M Hopkins, N Iadorola, RM Vieira, ...
Journal of clinical psychopharmacology 37 (3), 355, 2017
|The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder|
MJ Niciu, ND Iadarola, D Banerjee, DA Luckenbaugh, M Park, M Lener, ...
Journal of Psychopharmacology 31 (12), 1570-1577, 2017
|RGS4 and COMT risk variants are associated with brain structural alterations.|
MS Lener, SJ Goodnow, JA Wood, KV Chowdari, MS Keshavan, ...
Schizophrenia research 150 (1), 321, 2013
|RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine|
L Park, M Furey, A Nugent, C Farmer, J Ellis, J Szczepanik, M Lener, ...
Biological Psychiatry 83 (9), S305-S306, 2018
|330. A Principal Components Analysis of Depression and Anhedonia Scales: Illustrating the Heterogeneity of Depression|
E Ballard, D Luckenbaugh, J Yarrington, N Lally, M Lener, ...
Biological Psychiatry 81 (10), S135, 2017
|Clinical trial of the potassium channel activator diazoxide for major depressive disorder halted due to intolerability|
B Kadriu, S Yuan, C Farmer, AC Nugent, MS Lener, MJ Niciu, M Park, ...
Journal of clinical psychopharmacology 38 (3), 243, 2018
|1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression|
B Kadriu, P Gold, M Lener, E Ballard, M Niciu, P Yuan, D Luckenbaugh, ...
Biological Psychiatry 81 (10), S405-S406, 2017
|517. Effects of Ketamine on Atypical and Typical Symptoms of Depression|
K Yu, L Park, D Luckenbaugh, S Pennybaker, M Hopkins, M Lener, ...
Biological Psychiatry 81 (10), S210, 2017
|1004. Clinical Predictors of an Antisuicidal Response to Ketamine|
J Yarrington, E Ballard, D Luckenbaugh, M Niciu, M Lener, B Kadriu, ...
Biological Psychiatry 81 (10), S406, 2017